Human hepatocellular carcinoma expresses specific PCNA isoforms: An in vivo and in vitro evaluation

Laboratory Investigation

Volumn 88, Issue 9, 2008, Pages 995-1007

  Venturi, Annamaria ^a,b   Piaz, Fabrizio Dal ^c   Giovannini, Catia ^b   Gramantieri, Laura ^a,b   Chieco, Pasquale ^b   Bolondi, Luigi ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Hepatocellular carcinoma; Phosphorylation; Proliferating cell nuclear antigen; Two dimensional gel electrophoresis; Ubiquitylation

Indexed keywords

CYCLINE; DNA;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 50249159499     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.50     Document Type: Article

References (48)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
2. Scherman M. Alpha feto protein: an obituary. J Hepatol 2001;34:603-605.
3. Nagai H, Pineau P, Tiollais P, et al. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997;14:2927-2933.
4. Tsopanoumichalou M, Kouroumalis E, Ergazaki M, et al. Loss of heterozygosity and microsatellite instability in human non-neoplastic hepatic lesions. Liver 1999;19:305-311.
5. Yeh SH, Chen PJ, Shau WY, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001;121:699-709.
6. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-897.
7. Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002;297:547-551.
8. Tsurimoto T. PCNA binding proteins. Front Biosci 1999;4:D849-D858.
9. Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997;14:629-640.
10. Prosperi E. Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control. Prog Cell Cycle Research 1997;3:193-210.
11. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003;116:3051-3060.
12. Prosperi E. The fellowship of the ring: distinct pools of proliferating cell nuclear antigen at work. FASEB J 2006;20:833-837.
13. Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S-phase. Proc Natl Acad Sci USA 1985;82:3262-3266.
14. Bravo R, Macdonald-Bravo H. Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO J 1985;4:655-661.
15. Bravo R, Macdonald Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987;105:1549-1554.
16. Mathews MB, Bernstein RM, Franza Jr BR, et al. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-376.
17. Jonsson ZO, Hubscher U. Proliferating cell nuclear antigen: more than a clamp for DNA polymerases. Bioessays 1997;19:967-975.
18. Loor G, Zhang SJ, Zhang P, et al. Identification of DNA replication and cell cycle proteins that interact with PCNA. Nucleic Acids Res 1997;25:5041-5046.
19. Prosperi E, Scovassi AI, Stivala LA, et al. Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A. Exp Cell Res 1994;215:257-262.
20. Wang SC, Nakajima Y, Yu YL, et al. Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 2006;8:1359-1368.
21. Bravo R, Celis JE. Changes in the nuclear distribution of cyclin (PCNA) during S-phase are not triggered by post-translational modifications that are expected to moderately affect its charge. FEBS Lett 1985;182:435-440.
22. Naryzhny SN, Lee H. The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function. J Biol Chem 2004;279:20194-20199.
23. Hoelz DJ, Arnold RJ, Dobrolecki LE, et al. The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics 2006;6:4808-4816.
24. Hoege C, Pfander B, Moldovan GL, et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002;419:135-141.
25. Haracska L, Torres-Ramos CA, Johnson RE, et al. Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol Cell Biol 2004;24:4267-4274.
26. Haracska L, Unk I, Prakash L, et al. Ubiquitylation of yeast proliferating cell nuclear antigen and its implications for translesion DNA synthesis. Proc Natl Acad Sci USA 2006;103:6477-6482.
27. Kannouche PL, Lehmann AR. Ubiquitination of PCNA and the polymerase switch in human cells. Cell Cycle 2004;3:1011-1013.
28. Ulrich HD. How to activate a damage-tolerant polymerase: consequences of PCNA modifications by ubiquitin and SUMO. Cell Cycle 2004;3:15-18.
29. Ulrich HD. Deubiquitinating PCNA: a downside to DNA damage tolerance. Nat Cell Biol 2006;8:303-305.
30. Henderson DS, Wiegand UK, Norman DG, et al. Mutual correction of faulty PCNA subunits in temperature-sensitive lethal mus209 mutants of Drosophila melanogaster. Genetics 2000;154:1721-1733.
31. Naryzhny SN, Zhao H, Lee H. Proliferating cell nuclear antigen (PCNA) may function as a double homotrimer complex in the mammalian cell. J Biol Chem 2005;280:13888-13894.
32. Naryzhny SN, Desouza LV, Siu KW, et al. Characterization of the human proliferating cell nuclear antigen physico-chemical properties: aspects of double trimer stability. Biochem Cell Biol 2006;84:669-676.
33. Bechtel PE, Hickey RJ, Schnaper L, et al. A unique form of proliferating cell nuclear antigen is present in malignant breast cells. Cancer Res 1998;58:3264-3269.
34. Malkas LH, Herbert BS, Abdel-Aziz W, et al. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci USA 2006;103:19472-19477.
35. Kawakita N, Seki S, Sakaguchi H, et al. Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde. Am J Pathol 1992;140:513-520.
36. Gramantieri L, Trere D, Chieco P, et al. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. J Hepatol 2003;39:997-1003.
37. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
39. Herbert B, Galvani M, Hamdan M, et al. Reduction and alkylation of proteins in preparation of two-dimensional map analysis: why, when, and how? Electrophoresis 2001;22:2046-2057.
40. Sadaie MR, Mathews MB. Immunochemical and biochemical analysis of the proliferating cell nuclear antigen (PCNA) in HeLa cells. Exp Cell Res 1986;163:423-433.
41. Shevchenko A, Wilm M, Worm O, et al. Mass spectrometric sequencing of protein from silver stained polyacrilamide gels. Anal Chem 1996;68:850-858.
42. Naryzhny SN, Lee H. Observation of multiple isoforms and specific proteolysis patterns of proliferating cell nuclear antigen in the context of cell cycle compartments and sample preparation. Proteomics 2003;3:930-936.
43. Schivakumar CV, Brown DR, Deb S, et al. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol Cell Biol 1995;15:6785-6793.
44. Bauer GA, Burgers PM. The yeast analog of mammalian cyclin/proliferating- cell nuclear antigen interacts with mammalian DNA polymerase delta. PNAS 1988;85:7506-7510.
45. Yao N, Turner J, Kelman Z, et al. Clamp loading, unloading and intrinsic stability of the PCNA, beta and gp45 sliding clamps of human, E. coli and T4 replicases. Genes Cell 1996;1:101-113.
46. Barbour L, Xiao W. Regulation of alternative replication bypass pathways at stalled replication forks and its effects on genome stability: a yeast model. Mutat Res 2003;532:137-155.
47. Zhuo S, Clemens JC, Hakes DJ, et al. Expression, purification, crystallization, and biochemical characterization of a recombinant protein phosphatise. J Biol Chem 1993;268:17754-17761.
48. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signalling. Cell 1995;80:225-236.